7.96 USD
+0.03 (+0.38%)
ChartMill assigns a Buy % Consensus number of 82% to DERM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.77. This target is 72.99% above the current price.
DERM was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about DERM.
In the previous month the buy percentage consensus was at a similar level.
DERM was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-25 | HC Wainwright & Co. | Initiate | Buy |
| 2025-08-13 | Lake Street | Maintains | Buy -> Buy |
| 2025-07-30 | B. Riley Securities | Maintains | Buy -> Buy |
| 2024-09-06 | Lake Street | Initiate | Buy |
| 2024-08-22 | Rodman & Renshaw | Initiate | Buy |
| 2024-06-28 | Roth MKM | Reiterate | Buy |
| 2024-02-16 | Alliance Global Partners | Initiate | Buy |
| 2023-09-07 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2023-07-12 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-05-23 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-03-30 | B. Riley Securities | Reiterate | Buy |
| 2022-02-25 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-12-16 | Roth Capital | Initiate | Buy |
| 2021-12-07 | B. Riley Securities | Initiate | Buy |
JOURNEY MEDICAL CORP / DERM FAQ
What is the average price target for JOURNEY MEDICAL CORP (DERM) stock?
10 analysts have analysed DERM and the average price target is 13.77 USD. This implies a price increase of 72.99% is expected in the next year compared to the current price of 7.96.
Can you provide the consensus rating for JOURNEY MEDICAL CORP stock?
The consensus rating for JOURNEY MEDICAL CORP (DERM) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.